Tumour specificity of the SCM test for cancer diagnosis
- 1 October 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (10), 1165-1170
- https://doi.org/10.1016/0277-5379(85)90009-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Validation of the SCM-test for the diagnosis of cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseasesEuropean Journal of Cancer and Clinical Oncology, 1982
- Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancerCancer, 1980
- Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumour antigenEuropean Journal of Cancer (1965), 1979
- Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test)British Journal of Cancer, 1978
- Fluorescence-polarization changes in mononuclear blood leucocytes after PHA incubation: differences in cells from patients with and without neoplasiaBritish Journal of Cancer, 1978
- Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a reviewEuropean Journal of Cancer (1965), 1977
- Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti‐tumour immunity. III. “Blockade” of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patientsInternational Journal of Cancer, 1976
- Apparent tumour specificity with the SCM testBritish Journal of Cancer, 1975
- Biophysical Differentiation Between Lymphocytes from Healthy Donors, Patients with Malignant Diseases and Other DisordersBritish Journal of Cancer, 1974